Company: IPAR
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001753926-25-001703
Chunk: 40

Company: INTERPARFUMS INC
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 7
Chunk 40
---
three and nine months ended September 30, 2025 respectively, as compared to $0.4 million and $1.17 million for the corresponding periods of the prior year .

The following table summarizes stock option information as of September 30, 2025:

Shares

Weighted Average Exercise Price

Outstanding at January 1, 2025

248,430

$
103.00

Options forfeited

(7,100
)

121.22

Options exercised

(27,430
)

76.98

Outstanding at September 30, 2025

213,900

$
105.73

Options exercisable

103,250

$
82.55

Options available for future grants

499,495

As of September 30, 2025, the weighted average remaining contractual life of options outstanding is 2.8 years (1.0 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $2.1 million and $2.1 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $2.7 million.

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2025 and 2024 were as follows:

(In thousands)
 
September 30, 2025

September 30, 2024

Cash proceeds from stock options exercised
 
$
2,112

$
1,729

Tax benefits

205

272

Intrinsic value of stock options exercised

1,618

1,721

There were no options granted during the nine months ended September 30, 2025 and September 30, 2024.
 
Expected volatility is estimated based on the historic volatility of the Company’s common stock. The expected term of the option is estimated based on historical data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors maintain its current payout ratio as a percentage of earnings.
 
In March 2022, Interparfums SA, our 72% owned French subsidiary, approved a plan to grant an aggregate of 88,400 shares of its stock to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The corporate performance conditions were met and